Global Digital Dose Inhaler Market Size To Grow USD 5.98 Billion by 2030 | CAGR of 15.5%

Category: Healthcare


A PHP Error was encountered

Severity: Notice

Message: Undefined variable: table

Filename: press/detail.php

Line Number: 118


File: /home/admin/web/
Line: 118
Function: _error_handler

File: /home/admin/web/
Line: 720
Function: view

File: /home/admin/web/
Line: 89
Function: view

File: /home/admin/web/
Line: 295
Function: require_once

Global Digital Dose Inhaler Market worth $5.98 billion by 2030


According to a research report published by Spherical Insights & Consulting, the Global Digital Dose Inhaler Market Size to grow from USD 2.65 billion in 2021 to USD 5.98 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 15.5% during the forecast period.


Digital Dose Inhaler Market

Get more details on this report -

Request Free Sample PDF

Browse key industry insights spread across 212 pages with 124 market data tables and figures & charts from the report onGlobal Digital Dose Inhaler Market Size, Share, and COVID-19 Impact Analysis, By Product (Metered Dose Inhaler, Dry Powder Inhaler), By Type (Branded Medication, Generics Medication), by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030 " Get Detailed Report Description Here:


With the use of a digital dose inhaler, patients can administer themselves by quickly breathing an aerosolized dose of medication into their lungs in accordance with a predetermined dose. Digital inhalers have built-in sensors that track inspiratory flow and identify inhaler use in line with dose management and release. There are many different kinds of digital dose inhalers available on the market, two examples being metric dose inhalers (MDI) and dry powder inhalers (DPI). The most popular dose delivery technique for treating respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), and others is metered dose inhalers.


COVID 19 Impact

The demand for medical products including personal protective equipment like gloves, masks, and protective eyewear has increased since the COVID 19 epidemic broke out. The need for medical supplies continues to rise from both the general public and healthcare professionals due to the growing number of COVID 19 cases around the world. The major market participants have the chance to take advantage of this increase in medical supply demand in order to guarantee a sufficient supply of personal equipment on the international market. In reality, the pandemic has had a favourable effect on the global market for digital dose inhalers. Impacted is the market for digital dose inhalers.


Inhalation therapy devices like metres that inhalers combined with an e-dose counter, internet-connected and small inhalers, and others are being considerably revolutionised by the growing technological breakthroughs in the market for digital dose inhalers. To increase patient medication adherence and ensure that the right dosage is being given to patients, the major market players are primarily concentrating on connectivity technology. In addition to this, the rising demand for technologically advanced features like patient tracking and seamless data transfer adds the essential components that are projected to speed up market expansion.


On the other hand, rising drug costs, expensive device costs, a lack of public understanding about modern asthma treatments and devices, and other factors will restrain market expansion.


Product Insights

Metered Dose Inhaler segment is dominating the market with the largest market share over the forecast period

On the basis of product, the global digital dose inhaler market is segmented into metered dose inhaler and dry powder inhaler. Among these, metered dose inhaler segment is dominating the market with the largest market share over the forecast period. The growth is ascribed to rising healthcare costs, a rise in chronic heart disease cases, and the accessibility of metered dose inhalers. Additionally, the segmental growth is being boosted by continuous technological advancements in the production of inhalation medications, such as mechanistic pharmacokinetic in electronic monitoring systems and nanotechnology-based formulation in addition to high drug loads with reduced dose sizes.


Type Insights

Branded medication segment accounted the largest revenue share over the forecast period

Based on the type, the global digital dose inhaler market is segmented into branded medication and generics medication. Among these, the branded medication segment accounted the largest revenue share over the forecast period. This is a result of rising healthcare spending levels and rising demand for the development of new respiratory medications. In reality, the continued development of inhalation medicines and the rise in the use of branded drug inhalation are both attributed to the estimated penetration rate of these devices in the field of technology.


Regional Insights

North America is dominating the market with the largest market share over the forecast period


Digital Dose Inhaler Market

Get more details on this report -

Request Free Sample PDF

Over the projected period, North America will dominate the market for digital dose inhalers. The broad understanding of the current high-tech breathing equipment and the intensive research and development activities may be to blame. Furthermore, a rise in the prevalence of respiratory conditions among both the young and the elderly population would encourage market expansion.


On the other hand, over the anticipated period, Asia Pacific would have the fastest market expansion. Japan and China are the two main nations selected as hubs for the respiratory devices industry. The global market for digital dose inhalers is expected to grow as a result of a number of important factors, such as the growing weight of an ageing population, an increase in overall healthcare spending, and the rapidly changing nature of the healthcare sector.


Major vendors in the Global Digital Dose Inhaler Market include Glenmark Pharmaceuticals Ltd., Novartis AG, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Inc., Teva Pharmaceutical Industries Ltd., Gecko Health Innovations, Inc., Koninklijke Phillips N.V., GlaxoSmithKline Plc., AptarGroup Inc., Cipla, Inc..


Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Digital Dose Inhaler Market based on the below-mentioned segments:


Digital Dose Inhaler Market, Product Analysis

  • Metered dose inhaler
  • Dry powder inhaler

Digital Dose Inhaler Market, Type Analysis

  • Branded Medication
  • Generics Medication


Digital Dose Inhaler Market, Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa


About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 



For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)


Contact Us:

Follow Us: LinkedIn | Facebook | Twitter


Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies